Skip to main content

Tweets

NIH Complimentary Medicine overview of Music Therapy - preliminary research suggests that music interventions may be helpful for anxiety, depression, pain control, dementia, multiple sclerosis, Parkinson’s disease, etc https://t.co/UGsfT7lITQ https://t.co/DrJm4JdEuY
Dr. John Cush @RheumNow ( View Tweet )
9 months 3 weeks ago
EMA approved a record 28 biosimilars in 2024 for cancer, osteoporosis, macular degeneration, and immune-related diseases like plaque psoriasis, ulcerative colitis, and Crohn’s disease https://t.co/NNzKRalLvF https://t.co/nfX082a7ON
Dr. John Cush @RheumNow ( View Tweet )
9 months 3 weeks ago
Consensus on Bone Turnover Biomarkers in Osteoporosis A new consensus paper, published by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), the International Osteoporosis Foundation (IOF), and the https://t.co/lq1odNBLdZ
Dr. John Cush @RheumNow ( View Tweet )
9 months 4 weeks ago
Consensus Against Interventional Injections for Chronic Spinal Pain BMJ has published a clinical practice guideline resulting from the work of an international, multidisciplinary panel addressing chronic spine pain (≥3 months duration) not associated with cancer or https://t.co/PfXM210PsZ
Dr. John Cush @RheumNow ( View Tweet )
9 months 4 weeks ago
Vamorolone, a promising alternative to traditional glucocorticoids for inflammatory diseases. ◦ #Vamorolone is a dissociated steroid compound with reduced side effects. ◦ Unlike conventional #glucocorticoids, vamorolone lacks the hydroxyl or ketone groups and is resistant to https://t.co/yvDWqcbXbn
Alberto Giraldo @alb_giraldo ( View Tweet )
9 months 4 weeks ago
✅ IF YOU ARE LIVING WITH #LUPUS, you can now try #SLAKE, the ONLINE DIGITAL research tool for assessing your ESSENTIAL KNOWLEDGE about #SLE in English, German, Arabic, Spanish, Chinese, Français, Hindi, Indonesian, Dutch, etc... using the following LINK: https://t.co/nSCdBBMEcx https://t.co/PBAPkGynjP
Laurent ARNAUD @Lupusreference ( View Tweet )
9 months 4 weeks ago
Cancer Survival with TNF Inhibitors Dr. Jack Cush reviews the news and journal reports from this past week on https://t.co/V10S4oVFsv https://t.co/MKJKAi0BPV

Dr. John Cush @RheumNow ( View Tweet )

9 months 4 weeks ago
Patient Education handout on Raynaud’s Phenomenon https://t.co/Ug2MmtexgU https://t.co/kk9Klxhl8x
Dr. John Cush @RheumNow ( View Tweet )
9 months 4 weeks ago
A study in Alberta, Canada, examining the travel burdens for rheumatoid arthritis patients, found a median travel time of 13 minutes to reach general practitioners and 34 minutes to see rheumatologists. The research highlighted significant disparities between rural and urban https://t.co/2kYDrk16O8
Dr. John Cush @RheumNow ( View Tweet )
9 months 4 weeks ago
Obstacles to the current use of DMARDs from patients, discussed during regular appointments, were mainly associated with adverse effects and worries about effectiveness and long-term usage. Ongoing attention to these patients' concerns is crucial for improving treatment https://t.co/hWYGiPIsBb
Dr. John Cush @RheumNow ( View Tweet )
9 months 4 weeks ago
Diagnosing PMR is easy before Pred initiation; but after steroids NO SO. Before Pred, PMR Dx from non-PMR (median probabilities 7.8 vs 2.8) w/ 86% sensitivity/83% specificity. After Pred Dx probability of PMR dropped to 1.0 w/ sensitivity 3.5%; not much better w/ Pred D/C https://t.co/q4TceeFByc
Dr. John Cush @RheumNow ( View Tweet )
9 months 4 weeks ago
Repetitive Transcranial Magnetic Stimulation in Fibromyalgia A randomized, sham-controlled trial has shown that repetitive transcranial magnetic stimulation (rTMS) reduced pain in fibromyalgia for up to 8 weeks; while analgesic effects waned, functional improvements remained https://t.co/nJdSrUcizo
Dr. John Cush @RheumNow ( View Tweet )
9 months 4 weeks ago
×